Mylan Pharmaceuticals Inc. is recalling 5,790 cartons (approximately 526,890 tablets) of Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, which is an extended-cycle birth control medication. The recall was initiated because the individual blister packs inside the cartons contain the incorrect product name and NDC (National Drug Code) number. This labeling error could lead to confusion regarding the medication being taken, though the tablets themselves are the correct strength and dosage.
The incorrect product name and drug identifiers on the internal blister packs may cause patients to take the wrong medication or doubt the authenticity of their prescription, potentially leading to unintended pregnancy or dosing errors if the consumer is confused by the conflicting labels.
Healthcare provider consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.